Injection Drug Use, Hepatitis C, & HIV

Share on FacebookTweet about this on TwitterShare on LinkedIn

A substantial percentage of the excess mortality in HIV-infected injection drug users (IDUs) appears to be explained by hepatitis C coinfection, according to international research. Mortality was higher in IDUs than in non-IDUs, but the effect of injection drug use on mortality was substantially attenuated after adjusting for hepatitis C infection. Attenuation of the effect of hepatitis C was less substantial after adjustment for injection drug use.

Source: Journal of Acquired Immune Deficiency Syndromes, July 1, 2015.

An abstract of the study is available at

Submit a Comment

Your email address will not be published. Required fields are marked *

20 − 9 =